SCHEMBL24718656

SCHEMBL24718656

Cc1ccc(O)c(C(=O)N[C@@H]2CC(O)N(Cc3ccc(Cl)c(Cl)c3)C2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ MCHR1 Q99705 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ RAB9A P51151 3/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ LIPG Q9Y5X9 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ NLRP3 Q96P20 1/20 0.38
▸ CCR3 P51677 1/20 0.37
▸ GRM5 P41594 1/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ TAS1R3 Q7RTX0 1/20 0.37
▸ TAS1R1 Q7RTX1 1/20 0.37
▸ TAS1R2 Q8TE23 1/20 0.37
▸ SIGMAR1 Q99720 1/20 0.37
▸ UTS2R Q9UKP6 1/20 0.37
▸ DRD4 P21917 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24719132 1.00 MEN1 (0.43) MEN1KMT2AMCHR1SMN1; SMN2RAB9A
SCHEMBL24718822 0.85 P2RX1 (0.45) KDM4EDRD4DRD2HTR2A
SCHEMBL24719112 0.80 SMN1; SMN2 (0.44) MEN1KMT2AMCHR1SMN1; SMN2RAB9A
SCHEMBL24718657 0.80 SMN1; SMN2 (0.44) MEN1KMT2AMCHR1SMN1; SMN2RAB9A
SCHEMBL24719133 0.80 SMN1; SMN2 (0.44) MEN1KMT2AMCHR1SMN1; SMN2RAB9A
SCHEMBL24718379 0.69 POLB (0.45) MCHR1SMN1; SMN2POLBKDM4ELMNA
SCHEMBL24719109 0.67 MEN1 (0.47) MEN1KMT2AMCHR1RAB9ANPC1
SCHEMBL24718283 0.67 MEN1 (0.45) MEN1KMT2ASMN1; SMN2RAB9ANPC1
SCHEMBL24718823 0.66 P2RX1 (0.45) MEN1KMT2ASMN1; SMN2DRD4
SCHEMBL12900917 0.65 NPC1 (0.67) SMN1; SMN2RAB9ANPC1TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 MEN1 3534/4885KMT2A 180/4885MCHR1 3643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback